Stocksigma LogoStocksigma Logo

Sai Parenterals Board to Consider Q2 FY27 Results on 1st November 2026

Sai Parenterals Limited has scheduled a Board of Directors meeting on 1st Nov'26 to consider and approve the standalone and consolidated un-audited

Sai Parenterals Board to Consider Q2 FY27 Results on 1st November 2026

Sai Parenterals Ltd 路 Intimation 路 01 Nov 2026, 5:30 am

Sai Parenterals Board to Consider Q2 FY27 Results on 1st November 2026 Sai Parenterals Limited has scheduled a Board of Directors meeting on 1st Nov'26 to consider and approve the standalone and consolidated un-audited financial results along with the limited review report for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for all designated persons and their immediate relatives until 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Sai Parenterals Ltd

All Sai Parenterals Ltd announcements